1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
2. Stephenson RA. Population-based prostate cancer trends in the PSA era: data from the surveillance, epidemiology and end results (SEER) program. Monogr Urol 1998; 19: 3.
3. Smith DS, Catalona WJ, Herschman JD. Longitudinal screening for prostate cancer with prostate specific antigen. JAMA 1996; 276: 1309–1315.
4. Amling CL, Blute ML, Bergstrah EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 2000; 164: 101–105.
5. Pound CR, Partin AW, Epstein JI, et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control. Urol Clin North Am 1997; 24: 395–406.